SVLSF Iv, LLC, 10% Owner at KalVista Pharmaceuticals, Inc. (KALV), sold 524,940 shares at $26.70 ($14.0M) on 2019-03-18, disclosed to the SEC on 2019-03-20.
Open-market sale of $14.0M KALV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.70 | 7,246 | $193K | 1.4% |
| 2 | $26.70 | 7,246 | $193K | 1.4% |
| 3 | $26.70 | 255,224 | $6.8M | 48.6% |
| 4 | $26.70 | 255,224 | $6.8M | 48.6% |
| Total | $26.70 avg | 524,940 | $14.0M | 100% |
| Filing → |
| ENTL | BUY | 2015-02-04 | $5.4M | — | Filing → |
| OCUL | BUY | 2014-07-31 | $6.2M | — | Filing → |
| OPHT | SELL | 2014-06-02 | $25.5M | — | Filing → |